Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc scores highest on Earnings (80) and lowest on Torque (47). Its PosiPenta is 61.61 out of 100, better than most similar companies.
On the Penta Grid this week, Jazz Pharmaceuticals plc is Grid #2 of 17 in Ireland.
Compared with similar companies in the Healthcare sector in Ireland.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | 61.61 | 63 | 80 | 63 | 47 | 55 |
| Alkermes plc | 39.33 | 28 | 50 | 37 | 30 | 52 |
| Perrigo Company plc | 38.73 | 45 | 40 | 47 | 7 | 55 |
| Medtronic plc | 60.03 | 54 | 43 | 83 | 50 | 69 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 14.41 |
| P/B ratio | 2.84 |
EEarnings
| Trailing EPS | ₹1381.89 |
| Forward EPS | ₹2467.79 |
NNitro
| Price | 19911.92 |
| 52-week high | 25230.17 |
| 52-week low | 12199.29 |
| Fall from 52-week high | 21.1% |
TTorque
| Return on equity (ROE) | 22.11% |
| Debt-to-equity | 0.92 |
AAnchor
| Beta (price swings) | 0.37 |
| Market cap | ₹1,29,257 Cr |
| Insider holding | 2.90% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Jazz Pharmaceuticals plc's PosiPenta score?
Jazz Pharmaceuticals plc's PosiPenta is 61.61 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Jazz Pharmaceuticals plc stand on the Penta Grid?
On the Penta Grid this week, Jazz Pharmaceuticals plc is Grid #2 of 17 in Ireland.
Which PosiPenta pillar is strongest for Jazz Pharmaceuticals plc?
Earnings (growth), with a score of 80 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Jazz Pharmaceuticals plc?
Torque (durability), with a score of 47 out of 100: around the middle of similar companies.
Has Jazz Pharmaceuticals plc's PosiPenta changed since last week?
Yes, it fell 0.30 points, from 61.91 to 61.61.
PositoAI is for research and education only and is not investment advice.